Changes in serum potassium mediate thiazide-induced diabetes

Hypertension

Volumn 52, Issue 6, 2008, Pages 1022-1029

  Shafi, Tariq ^a   Appel, Lawrence J ^a,b,c   Miller III, Edgar R ^a,b,c   Klag, Michael J ^a,b,c   Parekh, Rulan S ^a,b,c  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Chlorthalidone; Diabetes mellitus; Hypertension; Hypokalemia; Potassium; Thiazide diuretics

Indexed keywords

ANTIDIABETIC AGENT; CHLORTALIDONE; GLUCOSE; POTASSIUM; THIAZIDE DIURETIC AGENT;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; DRUG INDUCED DISEASE; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HAZARD RATIO; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SELF REPORT; SYSTOLIC HYPERTENSION; TREATMENT DURATION; TREATMENT OUTCOME;

AGED; ANTIHYPERTENSIVE AGENTS; ATENOLOL; BLOOD PRESSURE; CHLORTHALIDONE; DIABETES MELLITUS, TYPE 2; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; HYPERTENSION; HYPOKALEMIA; INCIDENCE; MALE; MIDDLE AGED; POTASSIUM; PROPORTIONAL HAZARDS MODELS; RESERPINE; RISK FACTORS;

EID: 57449120453     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.108.119438     Document Type: Article

References (45)

1. Fields LE, Burt VL, Cutler JA, Hughes J, Roccella EJ, Sortie P. The burden of adult hypertension in the United States 1999 to 2000: a rising tide. Hypertension. 2004;44:398-404.
2. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet. 2005;365:217-223.
3. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42:1206-1252.
4. Kostis JB, Wilson AC, Freudenberger RS, Cosgrove NM, Pressel SL, Davis BR, Group SCR. Long-term effect of diuretic-based therapy on fatal outcomes in subjects with isolated systolic hypertension with and without diabetes. Am J Cardiol. 2005;95:29-35.
5. Barzilay JI, Davis BR, Cutler JA, Pressel SL, Whelton PK, Basile J, Margolis KL, Ong ST, Sadler LS, Summerson J. Fasting glucose levels and incident diabetes mellitus in older nondiabetic adults randomized to receive 3 different classes of antihypertensive treatment: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Arch Intern Med. 2006;166:2191-2201.
6. Verdecchia P, Angeli F, Reboldi G. New-onset diabetes, antihypertensive treatment, and outcome. Hypertension. 2007;50:459-460.
7. Houston MC. ALLHAT debate: diuretics are not preferred, first-line initial therapy for hypertension. Arch Intern Med. 2004;164:570-571.
8. Carter BL, Einhorn PT, Brands M, He J, Cutler JA, Whelton PK, Bakris GL, Brancati FL, Cushman WC, Oparil S, Wright JT Jr. Thiazide-induced dysglycemia: call for research from a working group from the national heart, lung, and blood institute. Hypertension. 2008;52:30-36.
9. Gorden P. Glucose intolerance with hypokalemia. Failure of short-term potassium depletion in normal subjects to reproduce the glucose and insulin abnormalities of clinical hypokalemia. Diabetes. 1973;22:544-551.
10. Rowe JW, Tobin JD, Rosa RM, Andres R. Effect of experimental potassium deficiency on glucose and insulin metabolism. Metab Clin Exp. 1980;29:498-502.
11. Panel on Dietary Reference Intakes for Electrolytes and Water. Chapter 5. Potassium. In: Dietary Reference Intakes for Water, Potassium, Sodium, Chloride, and Sulfate. Washington, DC: National Academies Press; 2004:186-268.
12. Sagild U, Andersen V, Andreasen PB. Glucose tolerance and insulin responsiveness in experimental potassium depletion. Acta Med Scand. 1961;169:243-251.
13. Rapoport MI, Hurd HF. Thiazide-induced glucose intolerance treated with potassium. Arch Intern Med. 1964;113:405-408.
14. Helderman JH, Elahi D, Andersen DK, Raizes GS, Tobin JD, Shocken D, Andres R. Prevention of the glucose intolerance of thiazide diuretics by maintenance of body potassium. Diabetes. 1983;32:106-111.
15. Cutler JA. Thiazide-associated glucose abnormalities: prognosis, etiology, and prevention: is potassium balance the key? Hypertension. 2006;48:198-200.
16. The Systolic Hypertension in the Elderly Program (SHEP). Available at: http://www.nhlbi.nih.gov/resources/deca/descriptions/shep.htm. Accessed September 2, 2008.
17. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA. 1991;265:3255-3264.
18. The Systolic Hypertension in the Elderly Program (SHEP) Cooperative Research Group. Rationale and design of a randomized clinical trial on prevention of stroke in isolated systolic hypertension. J Clin Epidemiol. 1988;41:1197-1208.
19. Twisk J, Proper K. Evaluation of the results of a randomized controlled trial: how to define changes between baseline and follow-up. J Clin Epidemiol. 2004;57:223-228.
20. Donders AR, van der Heijden GJ, Stijnen T, Moons KG. Review: a gentle introduction to imputation of missing values. J Clin Epidemiol. 2006;59:1087-1091.
21. Royston P. Multiple imputation of missing values: update. Stata J. 2005;5:188-201.
22. Rubin D. Multiple Imputation for Nonresponse in Surveys. New York, NY: Wiley; 1987.
23. Singer JD, Willett JB. Applied Longitudinal Data Analysis. New York, NY: Oxford University Press; 2003.
24. McAlister FA, Straus SE, Guyatt GH, Haynes RB. Users' guides to the medical literature: XX. Integrating research evidence with the care of the individual patient. Evidence-Based Medicine Working Group. JAMA. 2000;283:2829-2836.
25. Altman DG, Andersen PK. Calculating the number needed to treat for trials where the outcome is time to an event. BMJ. 1999;319:1492-1495.
26. Vittinghoff E, Shiboski SC, McCullouch CE, Glidden DV. Regression Methods in Biostatistics: Linear, Logistic, Survival and Repeated Measures Models. New York, NY: Springer Science+Business Media, Inc; 2005.
27. Sterns RH, Cox M, Feig PU, Singer I. Internal potassium balance and the control of the plasma potassium concentration. Medicine. 1981;60:339-354.
28. Savage PJ, Pressel SL, Curb JD, Schron EB, Applegate WB, Black HR, Cohen J, Davis BR, Frost P, Smith W, Gonzalez N, Guthrie GP, Oberman A, Rutan G, Probstfield JL, Stamler J. Influence of long-term, low-dose, diuretic-based, antihypertensive therapy on glucose, lipid, uric acid, and potassium levels in older men and women with isolated systolic hypertension: the Systolic Hypertension in the Elderly Program. SHEP Cooperative Research Group. Arch Intern Med. 1998;158:741-751.
29. Elliott WJ, Meyer PM. Incident diabetes in clinical trials of antihypertensive drugs: a network meta-analysis. Lancet. 2007;369:201-207.
30. Wilkins RW. New drugs for the treatment of hypertension. Ann Intern Med. 1959;50:1-10.
31. Kaplan NM, Carnegie A, Raskin P, Heller JA, Simmons M. Potassium supplementation in hypertensive patients with diuretic-induced hypokalemia. N Engl J Med. 1985;312:746-749.
32. Siegel D, Saliba P, Haffner S. Glucose and insulin levels during diuretic therapy in hypertensive men. Hypertension. 1994;23:688-694.
33. Zillich AJ, Garg J, Basu S, Bakris GL, Carter BL. Thiazide diuretics, potassium, and the development of diabetes: a quantitative review. Hypertension. 2006;48:219-224.
34. Phillips RA. New-onset diabetes mellitus less deadly than elevated blood pressure? Following the evidence in the administration of thiazide diuretics. Arch Intern Med. 2006;166:2174-2176.
35. Messerli FH, Bangalore S, Julius S. Risk/benefit assessment of {beta}-blockers and diuretics precludes their use for first-line therapy in hypertension. Circulation. 2008;117:2706-2715.
36. Sperling MA. ATP-sensitive potassium channels-neonatal diabetes mellitus and beyond. N Engl J Med. 2006;355:507-510.
37. Howell SL, Taylor KW. Potassium ions and the secretion of insulin by islets of Langerhans incubated in vitro. Biochem J. 1968;108: 17-24.
38. Burattini R, Di Nardo F, Boemi M, Fumelli P. Deterioration of insulin sensitivity and glucose effectiveness with age and hypertension. Am J Hypertens. 2006;19:98-102.
39. Kahn SE, Hull RL, Utzschneider KM. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature. 2006;444:840-846.
40. Pickkers P, Schachter M, Sever PS, Hughes AD. Do KCa channels and Carbonic anhydrase play a role in thiazide-induced hyperglycaemia? J Hum Hypertens. 1995;9:691-693.
41. Reungjui S, Roncal CA, Mu W, Srinivas TR, Sirivongs D, Johnson RJ, Nakagawa T. Thiazide diuretics exacerbate fructose-induced metabolic syndrome. J Am Soc Nephrol. 2007;18:2724-2731.
42. Chambers EC, Heshka S, Gallagher D, Wang J, Pi-Sunyer FX, Pierson RN Jr. Serum magnesium and type-2 diabetes in African Americans and Hispanics: a New York cohort. J Am Coll Nutr. 2006;25:509-513.
43. Kao WH, Folsom AR, Nieto FJ, Mo JP, Watson RL, Brancati FL. Serum and dietary magnesium and the risk for type 2 diabetes mellitus: the Atherosclerosis Risk in Communities Study. Arch Intern Med. 1999;159:2151-2159.
44. van Dam RM, Hu FB, Rosenberg L, Krishnan S, Palmer JR. Dietary calcium and magnesium, major food sources, and risk of type 2 diabetes in U.S. black women. Diabetes Care. 2006;29:2238-2243.
45. Song Y, He K, Levitan EB, Manson JE, Liu S. Effects of oral magnesium supplementation on glycaemic control in Type 2 diabetes: a meta-analysis of randomized double-blind controlled trials. Diabet Med. 2006;23:1050-1056.